BANK OF MONTREAL /CAN/
BankPosition in TEVA — Teva Pharmaceutical Industries Ltd
CIK 927971
TORONTO, A6
Position in TEVA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$32,917,229
+$6,431,360 QoQ
Shares Held
971,583
+10.5% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#87
of 675 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Dec 31, 2020CallValue
$4,075,195
CallShares
422,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BANK OF MONTREAL /CAN/ holds $180,170,999 across 30 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (18.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
588,398 | $42,282,277 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
971,583 | $32,917,229 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
776,464 | $26,920,005 | |
| 4 | VTRS |
Viatris Inc
|
1,275,750 | $20,258,907 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
224,707 | $18,601,244 | |
| 6 | HLN |
Haleon plc
|
908,864 | $8,479,699 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
13,342 | $7,229,093 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
35,697 | $6,016,371 |
All Filings in TEVA
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,917,229 | 971,583 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $26,485,869 | 879,345 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $38,640,037 | 1,238,066 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $16,825,466 | 832,944 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,976,701 | 475,937 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $6,313,163 | 410,746 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $8,997,212 | 408,222 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $7,352,428 | 408,015 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,723,582 | 413,759 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,996,503 | 354,111 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,724,111 | 356,716 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $3,638,175 | 356,684 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $2,711,105 | 360,041 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $3,251,638 | 367,417 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $4,415,755 | 484,184 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $19,668,929 | 2,437,290 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $12,751,653 | 1,695,699 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $35,788,546 | 3,811,347 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $16,208,369 | 2,023,517 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $27,027,193 | 2,774,866 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $34,277,520 | 3,462,376 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $2,959,408 | 256,448 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $4,075,195 | 422,300 | Call | Defined | 2021-02-12 | |
| 2020-12-31 | $2,482,518 | 257,256 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,323,731 | 368,894 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $4,532,752 | 367,620 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,796,000 | 200,000 | Put | Defined | 2020-05-13 | |
| 2020-03-31 | $2,220,617 | 247,285 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||